Major players in the fetal bovine serum market are Sartorius AG, GE Healthcare, PAN- Biotech, Thermo Fisher Scientific Inc., Biowest, Bio-Techne, Rocky Mountain Biologicals Inc., Merck KGaA, TCS Biosciences Ltd, Bovogen Biologicals Pty Ltd, Tissue Culture Biologicals, Atlanta Biologicals Inc., Atlas Biologicals, Acess Biologicals, Animal Technologies Inc, Nucleus Biologics, Corning Incorporated, J R Scientific Inc., Cytiva, Axil Scientific Pte Ltd, and Moregate Biotech.
The global fetal bovine serum market is expected to grow from $855.80 million in 2020 to $946.25 million in 2021 at a compound annual growth rate (CAGR) of 10.6%. The growth in mainly due to increase in R&D towards development of novel biopharmaceuticals. The market is expected to reach $1,175.36 million in 2025 at a CAGR of 5.6%.
The fetal bovine serum market consists of sales of fetal bovine serum by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing fetal bovine serum and related services.Fetal bovine serum refers to the liquid fraction of clotted blood from fetal calves, with reduced cells, fibrin, and clotting factors.
It has high concentration of nutritional and macromolecular factors essential for cell growth and is a critical raw material for animal care, biotechnology, drug development, diagnostics, and other fields of research.
The main types of fetal bovine serum are charcoal stripped, chromatographic, dialyzed fetal bovine serum, exosome depleted, stem cell, others.Charcoal stripped fetal bovine serum has activated carbon that helps lower levels of lipophilic compounds such as hormones, growth factors, and steroids and is used to conduct receptor or estrogen related studies.
Dialyzed fetal bovine serum has reduced concentration of low molecular weight components such as nucleotides, amino acids, hormones, salts and various small proteins in serum and is used in cell culture systems requiring a more defined environment of small molecules.Exosome depleted fetal bovine serum isolates exosomes from cultured cells without the complication of bovine exosomes that are present in conventional FBS and is used for research on exosomes.
The fetal bovine serum is used in drug discovery, cell culture media, in vitro fertilization, human and animal vaccine production, diagnostics, others. Fetal bovine serum is used in various sectors including research and academic institutes, biotechnology and pharmaceutical industry, others.
North America was the largest region in the fetal bovine serum market in 2020.Asia Pacific recorded the fastest growth during the forecast period.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Increasing collaborations between companies and research intuitions is a key trend gaining popularity in the fetal bovine serum market.Major companies are collaborating for increasing production capabilities, expanding market share and developing new products.
For instance, in 2017, US based GE Healthcare collaborated with New Zealand based Oritain for developing an independent test that can confirm the country of origin of fetal bovine serum (FBS) which would help biomanufacturing entities as FBS used in different countries pose different risk levels for virus contamination.
In December 2019, Sartorius, a German-based life science research and biopharmaceutical company acquired Biological Industries for $53.67 million. Through this acquisition, Sartorius expanded cell culture media and complementing the product portfolio for the users in the growing advanced therapies market in the majority portion of Biological Industries. Biological Industries is an Israel-based chemical and biotechnology company that provides fetal bovine serum for mammalian cell culture.
The increasing demand for biopharmaceuticals is expected to drive the growth of the fetal bovine serum market in the forecast period.A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology.
Fetal bovine serum (FBS) is the most widely used substitute for animal cell culture media.Pharmaceutical firms, diagnostic laboratories, and researchers rely heavily on FBS for much of their cell culture requirements in biologics research.
The global biologics market is expected to increase from $253.4 billion in 2020 to $420.5 billion by 2025. Therefore, the rising demand for biopharmaceuticals propels the growth of the fetal bovine serum market.
The countries covered in the Fetal Bovine Serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Our reports have been used by over 10K customers, including:
The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption,...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
This IDC Perspective illustrates how Debiopharm (a Swiss biopharmaceutical company) embarked on a digital transformation journey in which cybersecurity has become a top priority. This report highlights the key elements of this journey, including the adoption of artificial intelligence solutions to protect the intellectual property of its business...
The global instrument calibrator market is expected to grow from US$ 1,277.57 million in 2021 to US$ 1,854.03 million by 2028; it is estimated to grow at a CAGR of 5.5% during 2021–2028. Calibration is the process of comparing unknown values obtained for devices under test (DUT) to a known value reference standard.In pharmaceutical...
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021 Summary According to the recently published report ’5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021’; 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) pipeline Target constitutes close to 15 molecules. Out...
120 pages •
By Infiniti Research Limited
• Jul 2021
Global Chromatography Resins Market 2021-2025 The analyst has been monitoring the chromatography resins market and it is poised to grow by $ 1.22 bn during 2021-2025, progressing at a CAGR of almost 9% during the forecast period. Our report on chromatography resins market provides a holistic analysis, market size and forecast,...
45 pages •
By CCM Information Science & Technology Co., Ltd
• Jul 2021
If you subscribe annually, you can get a better price Vitamins China E-News provides you with real-time intelligence on China’s vitamins market. It is a monthly published newsletter, which can be downloaded in PDF format. The subscription period is yearly, grants the subscriber 12 issues in total. China...
Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Drugs In Development, 2021 Summary According to the recently published report ’Neuropeptide Y Receptor Type 2 - Drugs In Development, 2021’; Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) pipeline Target constitutes close to 5...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.